Literature DB >> 4175681

Studies on the metabolism of tryptophan in patients with benign prostatic hypertrophy or cancer of the prostate.

H Wolf, P O Madsen, J M Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4175681     DOI： 10.1016/s0022-5347(17)62566-7

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  3 in total

1.  Urinary Metabolomic and Proteomic Analyses in a Mouse Model of Prostatic Inflammation.

Authors:  Pingli Wei; Ling Hao; Fengfei Ma; Qing Yu; Amanda Rae Buchberger; Sanghee Lee; Wade Bushman; Lingjun Li
Journal:  Urine (Amst)       Date:  2020-05-27

Review 2.  The role of IDO in brain tumor immunotherapy.

Authors:  Lijie Zhai; Kristen L Lauing; Alan L Chang; Mahua Dey; Jun Qian; Yu Cheng; Maciej S Lesniak; Derek A Wainwright
Journal:  J Neurooncol       Date:  2014-12-18       Impact factor: 4.130

3.  A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma.

Authors:  Guangwei Xu; Tianqi Wang; Yongtao Li; Zhi Huang; Xin Wang; Jianyu Zheng; Shengyong Yang; Yan Fan; Rong Xiang
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.